President Trump announced a deal with Eli Lilly and Novo Nordisk on Thursday that would lower the cost of obesity drug prices for some patients on Medicare, Medicaid and the planned "TrumpRx" pharmaceutical website. Doctors spoke with CBS News about the deal.

See Full Page